Media
Corporate Governance
Investors
Career
Swedish
English
ENZY
4.84
SEK
0.94%
Enzyme science
Products
Research & Development
Company
Contact
Enzymatica Main Page
Investors
Financial reports
Investors
Financial reports
Financial reports 2011-2015 (in Swedish)
All years
2022
2021
2020
2019
2018
2017
2016
2015
2014
Type of information
Annual Reports
Interim Reports
April 28th 2022
Interim report Q1/2022: Our financial targets remain in place
March 31st 2022
Company presentation 2021
February 17th 2022
Year-end report: Clear signs of favourable market trends after a challenging 2021
November 2nd 2021
Interim Report Q3
July 16th 2021
Continued lower sales due to pandemic but some stabilization
April 29th 2021
Lower sales due to the pandemic but new rights issue secures continued international expansion
March 31st 2021
Enzymatica Publication of the Annual Report 2020
February 18th 2021
Positive operating result and almost doubled sales for the fourth quarter
November 3rd 2020
Continued strong sales increase and positive cash flow in third quarter
July 16th 2020
Doubled sales also during the second quarter
May 5th 2020
Doubled sales and positive earnings for the first quarter
February 13th 2020
ColdZyme – third largest cold brand in Sweden
November 5th 2019
Very strong increase of sales during the third quarter
July 17th 2019
Good growth in Q2, driven mainly by strong sales in Sweden
May 7th 2019
Continued strong growth in Sweden, but lower total sales during the quarter
February 19th 2019
Enzymatica AB: Strong sales in the fourth quarter, but lower sales for full-year 2018 driven by restrictions in Germany
October 31st 2018
Enzymatica AB: Breakthrough agreement for Japan and lower sales in Q3 due to restrictions in Germany
July 17th 2018
Enzymatica AB: Lower sales in Q2 but 31% increase for the first half of the year
April 26th 2018
Enzymatica AB: Continued growth during the first quarter
March 28th 2018
Enzymatica AB: Enzymatica - publication of the annual report 2017
February 14th 2018
Enzymatica AB: Strong growth and international breakthrough in 2017
November 1st 2017
Enzymatica AB: Interim report for Enzymatica AB (publ) January-September 2017
July 20th 2017
Enzymatica AB: Continued sales growth and breakthrough order from STADA
April 20th 2017
Enzymatica AB: Breakthrough in Germany and continued increase in sales
April 6th 2017
Enzymatica AB: Enzymatica - publication of the annual report 2016
February 16th 2017
Enzymatica AB: Geographic expansion and continued growth in 2016
July 18th 2016
Enzymatica AB: Excellent volume growth for ColdZyme®
April 20th 2016
Enzymatica - publication of the annual report 2015
April 18th 2016
Interim Report for Enzymatica AB (publ) January-March 2016
Enzymatica on First North Growth Market
Investment case
Risks
The share
Financial reports
Prospectus
Presentations
Financial calendar
Investor Relations Contact
Press releases
Subscribe